cobaltous chloride has been researched along with Pituitary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, W; Huang, L; Shen, X; Wang, D; Yang, Y; Zhu, X | 1 |
Arzt, E; Buchfelder, M; Fuertes, M; Gerez, J; Haedo, M; Losa, M; Renner, U; Shan, B; Stalla, GK; Theodoropoulou, M | 1 |
2 other study(ies) available for cobaltous chloride and Pituitary Neoplasms
Article | Year |
---|---|
Relationship between RSUME and HIF-1α/VEGF-A with invasion of pituitary adenoma.
Topics: Adenoma; Adult; Animals; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cobalt; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Middle Aged; Models, Biological; Neoplasm Invasiveness; Pituitary Neoplasms; RNA, Small Interfering; Signal Transduction; Transcription Factors; Vascular Endothelial Growth Factor A | 2017 |
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.
Topics: Adenoma; Animals; Cell Line, Tumor; Cobalt; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Neovascularization, Pathologic; Pituitary Neoplasms; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2012 |